LEO PHARMA INC
LEO PHARMA INC appears in FDA public data with 3 recalls, 0 510(k) clearances, 9 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0339-2026, Class II) was initiated on February 10, 2026.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 9
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0339-2026 | Class II | Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL | February 10, 2026 |
| D-0510-2017 | Class II | Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-87 | January 19, 2017 |
| D-0477-2017 | Class III | Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged | January 16, 2017 |